Vanguard Group Inc. Sells 500,564 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Vanguard Group Inc. lowered its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 0.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 111,646,375 shares of the real estate investment trust’s stock after selling 500,564 shares during the quarter. Vanguard Group Inc. owned 15.96% of Healthpeak Properties worth $2,263,072,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in DOC. Harvest Fund Management Co. Ltd bought a new stake in shares of Healthpeak Properties in the 4th quarter valued at approximately $30,000. Continuum Advisory LLC acquired a new stake in Healthpeak Properties in the 3rd quarter valued at $44,000. AdvisorNet Financial Inc grew its position in Healthpeak Properties by 34.5% in the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after acquiring an additional 563 shares during the period. Kestra Investment Management LLC acquired a new position in Healthpeak Properties during the fourth quarter worth $45,000. Finally, Assetmark Inc. raised its stake in Healthpeak Properties by 433.5% during the fourth quarter. Assetmark Inc. now owns 2,982 shares of the real estate investment trust’s stock worth $60,000 after acquiring an additional 2,423 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Up 0.8 %

Shares of NYSE DOC opened at $20.32 on Thursday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The firm has a market capitalization of $14.21 billion, a PE ratio of 58.04, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. The firm’s 50-day moving average is $20.25 and its 200-day moving average is $21.13. Healthpeak Properties, Inc. has a 1 year low of $17.70 and a 1 year high of $23.26.

Healthpeak Properties Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were issued a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 6.01%. The ex-dividend date was Friday, February 14th. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. Healthpeak Properties’s payout ratio is currently 348.57%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on DOC shares. Wedbush lowered their target price on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, February 14th. Robert W. Baird dropped their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Tuesday, February 11th. Scotiabank reduced their target price on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a report on Friday, February 28th. Mizuho dropped their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Finally, Wells Fargo & Company reduced their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 10th. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $23.92.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.